Simona Truglia | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases	REUMATISMO	2025
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease	REUMATISMO	2025
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation	THE JOURNAL OF RHEUMATOLOGY	2025
Interleukin-32 positive immune and resident cells in kidney samples from lupus patients: a pilot study.	FRONTIERS IN IMMUNOLOGY	2025
Antibody profiles in the mosaic of "seronegative" APS syndrome	CLINICAL AND EXPERIMENTAL IMMUNOLOGY	2024
Plasma CXCL4–DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment	REPORTS	2024
Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients. results from a cross-sectional analysis.	LUPUS	2024
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors.	REUMATISMO	2024
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life	RHEUMATOLOGY	2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective study	RHEUMATOLOGY	2024
Multicentre case-control study evaluating the safety of anti-SARS-CoV-2 vaccines in a cohort of patients with systemic vasculitis	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2023
Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study	RHEUMATOLOGY	2023
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib.	SCIENTIFIC REPORTS	2023
Carbamylation of β2-GPI generates new autoantigens for Antiphospholipid Syndrome. a new tool for diagnosis of "seronegative" patients	RHEUMATOLOGY	2022
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2022
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study	BIOMOLECULES	2022
Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome	FRONTIERS IN IMMUNOLOGY	2022
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2022
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)	THROMBOSIS AND HAEMOSTASIS	2022
Anti-vimentin/cardiolipin IgA in the antiphospholipid syndrome: a new tool for “seronegative” diagnosis	CLINICAL AND EXPERIMENTAL IMMUNOLOGY	2021